Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain @ Massachusetts General Hospital, Boston

Anxiety Disorder

Sublingual Cannabidiol for Anxiety @ McLean Hospital Brain Imaging Center, Massachusetts

Seizure & Epilepsy

Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder @ The University of California, San Francisco.


A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies @ Southwest Cancer Center Orlando, Florida

Mood Disorder

Cannabidiol as an Adjunctive Treatment for Bipolar Depression @ Hospital de Clínicas de Porto Alegre, Brazil.

Substance Abuse

Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse @ Mount Sinai Medical Center, New York

Parkinson Disease

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease @ University of Colorado hospital, Colorado

Inflammatory Bowl Disease

A Pilot Study of CBD in the Symptomatic Treatment of Ulcerative Colitis @ GW Research Ltd, Birmingham, United Kingdom

Research & CBD

Cannabidiol (CBD) (a plant derived cannabinoid) has demonstrated preliminary efficacy for a range of physical and mental health care problems.
CBD has attracted significant research interest due to its and anti-inflammatory, anti-oxidative and anti-necrotic protective effects, as well as displaying a favorable safety and tolerability profile in humans, making it a promising candidate in many therapeutic avenues including Chronic Pain, Epilepsy, Insomnia, Multiple Sclerosis, Migraine Headaches, Mood and Anxiety Disorders, Autoimmune Diseases, Cancer, Substance Abuse, Inflammatory Bowel Disease and so forth.
In the United States and all over the world, hundreds of randomized control trials are now being conducted in an ongoing effort to fully understand the healing power of CBD.
With very promising results found in animal and human studies, only time will tell when research will reveal CBD’s full potentiality, and what could be one of Mother Nature’s most prized gifts to all living things.

explore more

Consumers Use CBD For

Chronic & Joint Pain0%


Insomnia & Sleep Disorders0%


Migraine Headaches0%

Source: A Cross-Sectional Study of Cannabidiol Users, Jamie Corroon & Joy A. Phillips, 2018

Latest Findings

With over five hundred clinical research trials on Cannabidiol (CBD) currently being conducted, we will be updating you with the latest research findings here.


A large, well-controlled study of refractory pediatric epilepsy documented a beneficial effect of CBD in reducing seizure frequency by more than 50%.

Migraine Headaches

Cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.

The ``Runner's High``

In addition to endorphin release, the “runner’s high” experience after exercise has been shown to be induced in part by Anandamide (an endocannabinoid) acting on CB1 receptors, in mice.


In a large 2019 case series, CBD displays promise as a tool for reducing anxiety in clinical populations. Anxiety scores decreased within the first month in 79.2% of the subjects.

Depression | Neuroprotection

The activity of CBD at 5-HT1A receptors may drive its neuroprotective, antidepressive, and anxiolytic benefits.

Safety of CBD

Administration of CBD via different routes and long-term use of 10 mg/d to 400 mg/d did not create a toxic effect on patients. Doses up to 1500 mg/d have been well tolerated in the literature.

Conclusive Research Evidence

In January 2017, one of the most comprehensive and rigorous reviews of relevant scientific research published from 1999 to 2017, “Health Effects of Cannabis and Cannabinoids: Current State of Evidence and Recommendations for Research,” the ad hoc committee from the National Academies of Sciences, Engineering, and Medicine, states that there was research evidence that cannabis or cannabinoids (such as CBD) are therapeutic and effective for the treatment of the following ailments.

Reduction In Pain Symptoms

In adults with chronic pain, patients who were treated with cannabis or cannabinoids are more likely to experience a clinically significant reduction in pain symptoms

Improves Spasticity Symptoms In MS

In adults with Multiple Sclerosis (MS) related spasticity, shortterm use of oral cannabinoids improves patient-reported spasticity symptoms.

An Effective Antiemetic

In adults with chemotherapy induced nausea and vomiting, oral cannabinoids are effective antiemetics.

Our Partners

error: This Content Is © Protected !!